Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid

1 Aug 2022

Abstract excerpt

Background The AT(N) classification was proposed for categorising individuals according to biomarkers. However, AT(N) profiles may vary depending on the markers chosen and the target population. Methods We stratified 177 individuals who participated in the Japanese Alzheimer’s Disease Neuroimaging Initiative by AT(N) classification according to cerebrospinal fluid (CSF) biomarkers. We compared the frequency of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyotrophic Lateral Sclerosis Research
Share to Dementia and Cognitive Impairment Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36046332
DOI: 10.1136/bmjno-2022-000321

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluidPMID 36046332Read ↗

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease Semantic proximity Read ↗

Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity Read ↗

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read ↗

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without DementiaSemantic proximity Read ↗

ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degenerationSemantic proximity Read ↗

Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseasesSemantic proximity Read ↗

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKitSemantic proximity Read ↗

Atrophy subtypes and the ATN classification scheme in Alzheimer’s diseaseSemantic proximity Read ↗

CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysisSemantic proximity Read ↗

AT(N) predicts near-term development of Alzheimer’s disease symptoms in unimpaired older adultsSemantic proximity Read ↗

Comparison of variables associated with cerebrospinal fluid neurofilament, total‐tau, and neurograninSemantic proximity Read ↗

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.